*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Biochemical Biomarker Disorder Potential to Identify COVID-19 Patients in Iraq

Author: ALI A.H.ALBAKAA, THAER ALI HUSSEIN, WESSAM R.N.MOHSEN
Abstract: Background: A common effect of disease is disruption to serum electrolyte levels. Diseases responsible for this manifestation can be non-communicable or infectious. All aspects of patient care have been impacted by the (COVID-19) disease, occur due to infection with virus of SARS-CoV-2. Early studies of hospitalised COVID-19 patients report a putative relationship between the severity of infection and serum electrolytes, indicating these are potential diagnostic biomarkers of COVID-19 infection. Monitoring serum electrolytes as biomarkers of disease can assist with early diagnosis of COVID-19, as low or elevated concentrations of serum various electrolytes are associated with various inflammatory diseases. This study explores the effectiveness of using serum electrolytes as biomarkers for COVID-19 detection and clinically management of COVID-19 infected patients. Evaluation of efficacy of the method is determined by using a control group for comparison. The results reveal significant differences in the blood biochemical parameters among both study categories. The blood biochemistry picture of COVID-19 infected individuals is summarised. Methods: A total of 100 fully confirmed COVID-19 infected subjects that attending to specialist laboratory during the period from August 2020 to September-2020 were included in this study and evaluated for their serum level of biochemical biomarker (Mg, P, Ca, Na, Cl, K). Results: Of all the Covid-19 patients evaluated, we found that chloride (Cl) and magnesium (Mg) were respectively elevated in 20% and 15% of patients. Five per cent of patients had abnormal levels of phosphorus (P) and 73% of patients had reduced serum calcium (Ca), though it was increased in 1% of patients. Serum levels of potassium (K) were elevated in 37%, while 19% of patients had abnormal levels of sodium (Na). Conclusions: The range of serum electrolyte abnormalities exhibited by some COVID-19 patients might indicate varying degrees of organ dysfunction. The severity of the disease may be reflected to an extent in abnormal biochemical readings of (Ca) and (Na), for example. The results of this study indicate that serum concentrations of electrolytes have clinical implications for the management of COVID-19 patient; therefore, to help provide the most appropriate care for these patients, blood tests should be performed to evaluate these biomarkers.
Keyword: Biochemical Biomarker Characteristics, Diagnostic Utility, Coronavirus Disorder 2019.
DOI: https://doi.org/10.31838/ijpr/2020.12.04.476
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free